SMS Pharmaceuticals Ltd Q1 FY25 consolidated profit at Rs. 16.47 crores

SMS Pharmaceuticals Limited has reported Consolidated financial results for the period ended June 30, 2024.

Financial Results (Q1 FY2025) - QoQ Comparison

The company has reported total income of Rs. 165.8189 crores during the period ended June 30, 2024 as compared to Rs. 247.4440 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs. 16.4794 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 17.2790 crores for the period ended March 31, 2024.

The company has reported EPS of Rs. 1.95 for the period ended June 30, 2024 as compared to Rs. 2.04 for the period ended March 31, 2024.

Financials	Q1 FY2025	Q4 FY2024	% Change
Total Income	₹165.8189 crs	₹247.4440 crs	-32.99%
Net Profit	₹16.4794 crs	₹17.2790 crs	-4.63%
EPS	₹1.95	₹2.04	-4.41%

Financial Results (Q1 FY2025) - YoY Comparison

The company has reported total income of Rs.165.8189 crores during the period ended June 30, 2024 as compared to Rs.135.8523 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs.16.4794 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.9.3416 crores for the period ended June 30, 2023.

The company has reported EPS of Rs.1.95 for the period ended June 30, 2024 as compared to Rs.1.10 for the period ended June 30, 2023.

Financials	Q1 FY2025	Q1 FY2024	% Change
Total Income	₹165.8189 crs	₹135.8523 crs	22.06%
Net Profit	₹16.4794 crs	₹9.3416 crs	76.41%
EPS	₹1.95	₹1.10	77.27%

Shares of SMS Pharmaceuticals Limited was last trading in BSE at Rs. 309.20 as compared to the previous close of Rs. 312.55. The total number of shares traded during the day was 83806 in over 3557 trades.

The stock hit an intraday high of Rs. 324.75 and intraday low of 294.55. The net turnover during the day was Rs. 25449246.00.

Source : Equity Bulls

Keywords

SMSPharmaceuticals Q1FY25 FY2025 Q1FY2025 ResultUpdate